Beckman Symposium Program

Overcoming Resistance to Cancer Immunotherapy
The 28th Beckman Symposium
November 2, 2018

 
8:30 to 9 a.m.
Registration
 
9 to 9:10 a.m. - Welcome
Steven Rosen, M.D.
Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and 
Beckman Research Institute
Irell & Manella Cancer Center Director's Distinguished Chair 
SPOC Co-Chairman 
 
9:10 to 9:20 a.m. - Overview of Morning Session
Hua Yu, Ph.D.
Billy and Audrey L. Wilder Professor in Tumor Immunotherapy, Associate Chair and Professor, Department of Immuno-Oncology
Co-leader, Cancer Immunotherapeutics Program, Comprehensive Cancer Center, City of Hope                  
 
Marcin Kortylewski, Ph.D.
Associate Professor
Department of Immuno-Oncology
Beckman Research Institute
City of Hope National Medical Center
 
9:20 to 10:10 a.m.
Ira Mellman, Ph.D.
Vice President, Cancer Immunology, Genetech
'The mechanistic basis of cancer immunotherapy'

10:10 to 10:30 a.m. - BREAK
 
10:30 to 11:20 a.m.
Judith Varner, Ph.D.
Professor, Pathology, University of California San Diego
'Macrophage control of anti-tumor immunity'
 
11:20 a.m. to 12:10 p.m.
Shu-Hsia Chen, Ph.D.
Emily Herrmann Chair in Immunology Research, Cancer Center
Director, Center for Immunotherapy Research
Houston Methodist
'Blocking immunoinhibitory receptor reprograms tumor-associated myeloid cells and promotes antitumor immunity'
 
12:10 to 1:10 p.m. - LUNCH
 
1:10 to 1:20 p.m. - Overview of Afternoon Session
Peter Lee, M.D.
Billy Wilder Endowed Professor
Chair, Dept. of Immuno-Oncology
City of Hope Comprehensive Cancer Center

1:20 to 2:10 p.m.
Sandra Demaria, M.D.
Department of Radiation Oncology and Pathology and laboratory medicine, Weill Cornell Medicine, New York
'Mechanisms regulating the synergy of radiotherapy and immune checkpoint blockade'
 
2:10 to 2:50 p.m.
Edgar Engleman, M.D.
Professor of Pathology and of Medicine, Standford University
Investigating the basis for efficacy and resistance to tumor immunotherapy
 
2:50 to 3:10 - BREAK
 
3:10 to 4 p.m.
Leonid Metelitsa, M.D.

Professor, Pediatrics-Oncology, Baylor College of Medicine
'Allogeneic NKT cells as a platform for off-the-shelf cancer immunotherapy'
 
4 to 4:50 p.m.
Hong Qin, Ph.D.
Associate Research Professor 
Toni Stephenson Lymphoma Center
Department of Hematology and Hematopoietic Stem Cell Transplantation 
City of Hope National Medical Center
'Novel BAFF-R-chimeric antigen receptor T-cell therapy for antigen loss relapsed B-cell tumors'
 
4:50 to 5 p.m. - Closing Remarks
Larry W. Kwak, M.D.
Vice President and Deputy Director,
Comprehensive Cancer Center 
Director, Toni Stephenson Lymphoma Center
Dr. Michael Friedman Professor for Translational Medicine
SPOC Co-Chairman
 
*Schedule time subject to change